Monitoring bone density in older women is unnecessary and potentially misleading — Value of routine monitoring of bone mineral density after starting bisphosphonate treatment. – Monitoring bone mineral density in postmenopausal women taking osteoporosis drugs (bisphosphonates) is unnecessary and potentially misleading, revealed by researchers through a new study published on bmj.com.
Menopause transition may cause trouble learning – The largest study of its kind to date shows that women may not be able to learn as well shortly before menopause compared to other stages in life. The research is published in the May 26, 2009, print issue of Neurology, the medical journal of the American Academy of Neurology.
HRT-breast cancer risk stays same, regardless of family history – HRT conveys no greater breast cancer risk to women with, versus without, a first-degree family history of breast cancer. – The risk of developing breast cancer due to taking hormone replacement therapy appears to be the same for women with a family history of the disease and without a family history, a University of Rochester Medical Center study concluded.
Hormone therapy offers potential protective effect against colon cancer in older women – In a large study, a national team of researchers led by Mayo Clinic scientists observed that self-reported use of hormone therapy was associated with a significantly lower colorectal cancer risk. However, the mechanisms for the apparent protective association are still unclear.
Moms who breastfeed less likely to develop heart attacks or strokes and cardiovascular disease. – The longer women breastfeed, the lower their risk of heart attacks, strokes and cardiovascular disease, report University of Pittsburgh researchers in a study published in the May issue of Obstetrics & Gynecology.
Ovarian cancer screening would be feasible in primary care, according to the early results of a major Department of Health, UK funded analysis. – Blood test combined with ultrasound scan can diagnose ovarian cancer (gynecological cancer) early in postmenopausal women, almost 2 years earlier than normal, reported by the British researchers in the Lancet.
Red wine vs. white? It makes no difference when it comes to breast-cancer risk – The largest study of its kind to evaluate the effect of red versus white wine on breast-cancer risk concludes that both are equal offenders when it comes to increasing breast-cancer risk.
Long-term multivitamin use has no impact on the risk of common cancers, cardiovascular disease or overall mortality in postmenopausal women. – The largest study ever conducted on postmenopausal women shows that multivitamins may offer no benefit in reducing the risk of common cancers, cardiovascular disease or overall mortality.
Reduced breast cancer risk: Physical activity after menopause pays off – Several studies had previously suggested that regular physical exercise reduces the breast cancer risk of women. However, it had been unknowned just how much exercise women should take in which period in life in order to benefit from this protective effect.
Study links obese women are at an increased risk of developing ovarian cancer compared with women of normal weight. – A new epidemiological study has found that among women who have never used menopausal hormone therapy, obese women are at an increased risk of developing ovarian cancer compared with women of normal weight.
